FI953256L - Hyperglykemian vastaisesti vaikuttava lääkeaine - Google Patents

Hyperglykemian vastaisesti vaikuttava lääkeaine Download PDF

Info

Publication number: FI953256L
Authority: FI; Finland
Prior art keywords: antihyperglycemic drug; antihyperglycemic; drug
Prior art date: 1994-07-01

Application number

FI953256A

Other languages

English (en)

Swedish (sv)

Other versions

FI117374B (fi

FI953256A0 (fi

Inventor

Elbert Kaan

Dieter Ziegler

Reinhard Brueckner

Original Assignee

Kali Chemie Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-01

Filing date

1995-06-30

Publication date

1996-01-02

1995-06-30 Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh

1995-06-30 Publication of FI953256A0 publication Critical patent/FI953256A0/fi

1996-01-02 Publication of FI953256L publication Critical patent/FI953256L/fi

2006-09-29 Application granted granted Critical

2006-09-29 Publication of FI117374B publication Critical patent/FI117374B/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Dental Preparations (AREA)
Fats And Perfumes (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

FI953256A 1994-07-01 1995-06-30 Hyperglykemian vastaisesti vaikuttavat lääkeaineet FI117374B (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4423177A DE4423177A1 (de)	1994-07-01	1994-07-01	Antihyperglykämisch wirksame Arzneimittel
DE4423177		1994-07-01

Publications (3)

Publication Number	Publication Date
FI953256A0 FI953256A0 (fi)	1995-06-30
FI953256L true FI953256L (fi)	1996-01-02
FI117374B FI117374B (fi)	2006-09-29

Family

ID=6522064

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI953256A FI117374B (fi)	1994-07-01	1995-06-30	Hyperglykemian vastaisesti vaikuttavat lääkeaineet

Country Status (23)

Country	Link
US (1)	US5712283A (fi)
EP (1)	EP0689837B1 (fi)
JP (1)	JP3841846B2 (fi)
KR (1)	KR100366130B1 (fi)
CN (1)	CN1092961C (fi)
AT (1)	ATE210444T1 (fi)
AU (1)	AU691580B2 (fi)
CA (1)	CA2152998C (fi)
CZ (1)	CZ287563B6 (fi)
DE (2)	DE4423177A1 (fi)
DK (1)	DK0689837T3 (fi)
DZ (1)	DZ1894A1 (fi)
ES (1)	ES2167385T3 (fi)
FI (1)	FI117374B (fi)
HU (1)	HU226946B1 (fi)
IL (1)	IL113411A (fi)
NO (1)	NO307029B1 (fi)
NZ (1)	NZ270990A (fi)
PT (1)	PT689837E (fi)
RU (1)	RU2145857C1 (fi)
SK (1)	SK282227B6 (fi)
UA (1)	UA27954C2 (fi)
ZA (1)	ZA954691B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996026728A2 (en) *	1995-02-28	1996-09-06	Beiersdorf-Lilly Gmbh	Use of moxonidine for the treatment of atherosclerosis
HUP0003885A2 (hu) *	1996-06-06	2001-04-28	Eli Lilly And Co.	Készítmény pangásos szívelégtelenség kezelésére
ZA981029B (en) *	1997-02-11	1999-08-10	Lilly Co Eli	Pharmaceutical agents.
DE19722322A1 (de) *	1997-05-28	1998-12-03	Solvay Pharm Gmbh	Nephroprotektives Arzneimittel
JP2001520195A (ja) *	1997-10-17	2001-10-30	イーライ・リリー・アンド・カンパニー	医薬の増強
US6897019B1 (en) *	1998-04-17	2005-05-24	Tufts College	Methods for treating and preventing insulin resistance and related disorders
AU2727400A (en) *	1999-01-29	2000-08-18	Eli Lilly And Company	Moxonidine salts
RU2261097C2 (ru) *	1999-02-01	2005-09-27	Зольвай Фармасьютиклз Гмбх	Применение моксонидина для лечения постинфарктных состояний
DE19911371A1 (de)	1999-03-15	2000-09-21	Solvay Pharm Gmbh	Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
RU2219930C2 (ru) *	2001-09-24	2003-12-27	Государственное образовательное учреждение высшего профессионального образования Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова	Способ лечения заболеваний печени
PL372695A1 (en) *	2002-06-19	2005-07-25	Solvay Pharmaceuticals Gmbh	Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
ES2304624T3 (es) *	2003-10-10	2008-10-16	Solvay Pharmaceuticals Gmbh	Composicion farmaceutica que comprende un agonista selectivo del receptor de imidazolina l1 y un bloqueador del receptor de angiotensina ii.
RU2426543C1 (ru) *	2010-05-24	2011-08-20	Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН НИИ фармакологии СО РАМН	Способ дифференцированного назначения моксонидина у пациентов с артериальной гипертензией на фоне метаболического синдрома
RU2542462C2 (ru) *	2013-06-28	2015-02-20	Андрей Владиславович Струтынский	Способ коррекции кризового течения гипертонической болезни и абдоминального ожирения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4323570A (en) *	1978-11-15	1982-04-06	Beiersdorf Aktiengesellschaft	Substituted aminopyrimidines
DE2849537C2 (de) *	1978-11-15	1983-03-17	Beiersdorf Ag, 2000 Hamburg	Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FR2669927B1 (fr) *	1990-11-29	1994-04-08	Adir Cie	Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

1994
- 1994-07-01 DE DE4423177A patent/DE4423177A1/de not_active Withdrawn
1995
- 1995-04-18 IL IL11341195A patent/IL113411A/xx not_active IP Right Cessation
- 1995-04-26 NZ NZ270990A patent/NZ270990A/en unknown
- 1995-04-27 AU AU17757/95A patent/AU691580B2/en not_active Ceased
- 1995-05-20 KR KR1019950012695A patent/KR100366130B1/ko not_active Expired - Fee Related
- 1995-05-30 DZ DZ950067A patent/DZ1894A1/fr active
- 1995-05-30 CZ CZ19951393A patent/CZ287563B6/cs not_active IP Right Cessation
- 1995-06-01 RU RU95109157A patent/RU2145857C1/ru not_active IP Right Cessation
- 1995-06-06 SK SK749-95A patent/SK282227B6/sk not_active IP Right Cessation
- 1995-06-07 ZA ZA954691A patent/ZA954691B/xx unknown
- 1995-06-20 US US08/492,656 patent/US5712283A/en not_active Expired - Lifetime
- 1995-06-23 PT PT95109812T patent/PT689837E/pt unknown
- 1995-06-23 AT AT95109812T patent/ATE210444T1/de active
- 1995-06-23 EP EP95109812A patent/EP0689837B1/de not_active Expired - Lifetime
- 1995-06-23 DK DK95109812T patent/DK0689837T3/da active
- 1995-06-23 ES ES95109812T patent/ES2167385T3/es not_active Expired - Lifetime
- 1995-06-23 DE DE59509928T patent/DE59509928D1/de not_active Expired - Lifetime
- 1995-06-26 UA UA95062992A patent/UA27954C2/uk unknown
- 1995-06-28 HU HU9501900A patent/HU226946B1/hu not_active IP Right Cessation
- 1995-06-29 CA CA002152998A patent/CA2152998C/en not_active Expired - Fee Related
- 1995-06-30 NO NO19952624A patent/NO307029B1/no not_active IP Right Cessation
- 1995-06-30 FI FI953256A patent/FI117374B/fi not_active IP Right Cessation
- 1995-06-30 CN CN95107767A patent/CN1092961C/zh not_active Expired - Fee Related
- 1995-07-03 JP JP16770595A patent/JP3841846B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2152998A1 (en)	1996-01-02
ATE210444T1 (de)	2001-12-15
US5712283A (en)	1998-01-27
CZ287563B6 (en)	2000-12-13
SK74995A3 (en)	1996-05-08
JP3841846B2 (ja)	2006-11-08
DE4423177A1 (de)	1996-01-04
PT689837E (pt)	2002-04-29
CZ139395A3 (en)	1996-01-17
RU2145857C1 (ru)	2000-02-27
EP0689837A2 (de)	1996-01-03
KR960003729A (ko)	1996-02-23
JPH0840906A (ja)	1996-02-13
NZ270990A (en)	1997-06-24
ZA954691B (en)	1996-01-29
HUT72599A (en)	1996-05-28
DK0689837T3 (da)	2002-03-11
NO952624L (no)	1996-01-02
IL113411A (en)	1999-07-14
DZ1894A1 (fr)	2002-02-17
NO307029B1 (no)	2000-01-31
IL113411A0 (en)	1995-07-31
ES2167385T3 (es)	2002-05-16
KR100366130B1 (ko)	2003-03-26
HU9501900D0 (en)	1995-08-28
NO952624D0 (no)	1995-06-30
FI117374B (fi)	2006-09-29
AU691580B2 (en)	1998-05-21
EP0689837B1 (de)	2001-12-12
EP0689837A3 (de)	1996-06-05
FI953256A0 (fi)	1995-06-30
SK282227B6 (sk)	2001-12-03
HU226946B1 (en)	2010-03-29
DE59509928D1 (de)	2002-01-24
CN1092961C (zh)	2002-10-23
AU1775795A (en)	1996-01-18
CN1122224A (zh)	1996-05-15
UA27954C2 (uk)	2000-10-16
CA2152998C (en)	2002-09-03

Publication	Publication Date	Title
FI971279A0 (fi)	1997-03-26	Lääkkeitä
NO964106D0 (no)	1996-09-27	Spröyte
FI970995L (fi)	1997-04-25	Farmaseuttisia yhdisteitä
FI971018L (fi)	1997-04-18	Farmaseuttisia yhdisteitä
DE69510024D1 (de)	1999-07-08	Spritze
IS5425A (is)	2000-03-31	Læknislyf
FI973243L (fi)	1997-08-06	Uusi farmaseuttinen yhdistelmä
DE69534990D1 (de)	2006-06-22	Kontrastmittel
FI954243A7 (fi)	1996-03-13	Farmaseuttiset yhdisteet
FI953256L (fi)	1996-01-02	Hyperglykemian vastaisesti vaikuttava lääkeaine
BR9600809A (pt)	1997-12-23	Medicamento
BR9508339A (pt)	1997-09-30	Medicamento
BR9507768A (pt)	1997-09-02	Composição farmacêutica
DE69522857D1 (de)	2001-10-31	Insulinstandardlösung
DE59602953D1 (de)	1999-10-07	Fungizide wirkstoffkombinationen
FI951155L (fi)	1995-09-15	Farmaseuttinen valmiste
DE59602890D1 (de)	1999-09-30	Fungizide wirkstoffkombinationen
FI950737A7 (fi)	1995-08-19	Lääkkeitä
KR950022649U (ko)	1995-08-18	약탕기
KR950022733U (ko)	1995-08-18	세척기
NO944330D0 (no)	1994-11-14	Legemiddel
SE9401674L (sv)	1995-11-17	Läkemedel
SE9402131D0 (sv)	1994-06-14	Läkemedel
FI101604B1 (fi)	1998-07-31	Annosteluruisku
KR950026744U (ko)	1995-10-16	주사기

Legal Events

Date	Code	Title	Description
1997-08-08	GB	Transfer or assigment of application	Owner name: SOLVAY PHARMACEUTICALS GMBH
2006-09-29	FG	Patent granted	Ref document number: 117374 Country of ref document: FI
2012-05-21	PC	Transfer of assignment of patent	Owner name: ABBOTT PRODUCTS GMBH
2013-01-07	PC	Transfer of assignment of patent	Owner name: ABBOTT LABORATORIES GMBH
2015-01-15	MM	Patent lapsed